Skip to main content
OpenTrials

Clinical trial condition

Myeloproliferative Disorders

Explore clinical trials studying Myeloproliferative Disorders. Study availability and eligibility vary by location and protocol.

1,107 public trials 145 recruiting studies
Refine in advanced search Browse all conditions

Myeloproliferative Disorders trial results

Active, Not Recruiting

A Study to Access Efficacy and Safety of P1101 in Chinese PV Patients Who Are Intolerant or Resistance to HU

NCT05485948

Conditions
Bone Marrow Diseases, Bone Marrow Neoplasms, Hematologic Diseases, +6 more
Locations
  • Peking Union Medical College Hospital Beijing, China
  • Xiangya Hospital Central South University Changsha, China
  • The First Affiliated Hospital of Chongqing Medical Universit Chongqing, China
  • Nanfang Hospital affiliated to Southern Medical University Guangzhou, China
View all 14 locations
View Trial Details
Active, Not Recruiting

Safety and Tolerability Study of Oral ABBV-744 Tablet Alone or in Combination With Oral Ruxolitinib Tablet or Oral Navitoclax Tablet in Adult Participants With Myelofibrosis

NCT04454658

Conditions
Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +4 more
Locations
  • University of California, Davis Comprehensive Cancer Center /ID# 221790 Sacramento, California, United States
  • Duplicate_Dartmouth-Hitchcock Medical Center - 1 Medical Center Drive /ID# 224623 Lebanon, New Hampshire, United States
  • Roswell Park Cancer Institute /ID# 222557 Buffalo, New York, United States
  • The Mount Sinai Hospital /ID# 221549 New York, United States
View all 43 locations
View Trial Details
Active, Not Recruiting

The Ruxo-BEAT Trial in Patients With High-risk Polycythemia Vera or High-risk Essential Thrombocythemia

NCT02577926

Conditions
Blood Coagulation Disorders, Blood Platelet Disorders, Bone Marrow Diseases, +13 more
Locations
  • Universitätsmedizin Mannheim III. Medizinische Klinik Hämatologie und Internistische Onkologie Mannheim, Baden-Wurttemberg, Germany
  • Universitätsklinikum Ulm Klinik für Innere Medizin III Ulm, Baden-Wurttemberg, Germany
  • Rems-Murr Klinikum Winnenden Winnenden, Baden-Wurttemberg, Germany
  • Studienzentrum Aschaffenburg Aschaffenburg, Bavaria, Germany
View all 23 locations
View Trial Details
Active, Not Recruiting

The Study for CML Who Failed Prior TKIs or With T315I Mutation or Ph+ ALL Who Failed Prior TKIs or With T315I Mutation

NCT04233346

Conditions
Acute Lymphoblastic Leukemia, Bone Marrow Diseases, Chronic Disease, +18 more
Locations
  • Anhui Provincial Hospital Hefei, Anhui, China
  • The First Affiliated Hospital of Anhui Medical University Hefei, Anhui, China
  • Nanfang Hospital of Southern Medical University Guangzhou, Guangdong, China
  • Tongji Hospital Affiliated to Tongji Medical College, Huazhong University of Science and Technology Wuhan, Hubei, China
View all 14 locations
View Trial Details
Active, Not Recruiting

Frontline Asciminib Combination in Chronic Phase CML

NCT03906292

Conditions
Bone Marrow Diseases, Chronic Disease, Chronic Myeloid Leukemia, +11 more
Locations
  • Universitätsklinikum Aachen Medizinische Klinik IV Aachen, Germany
  • Charite Universitätsmeditin Berlin, Campus Virchow Klinikum Berlin, Germany
  • Universitätsklinikum Bonn Bonn, Germany
  • Klinikum Bremen Mitte Bremen, Germany
View all 21 locations
View Trial Details
Active, Not Recruiting

Unraveling the Role of Extracellular Vesicles-driven Senescence in Myeloproliferative Neoplasms

NCT06798805

Conditions
Blood Coagulation Disorders, Blood Platelet Disorders, Bone Marrow Diseases, +15 more
Locations
  • IRCCS Azienda Ospedaliero-Universitaria di Bologna Bologna, Italy
  • ASST Spedali Civili di Brescia Brescia, BS, Italy
  • Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori- IRST Meldola, FC, Italy
  • Ospedale S.Maria delle Croci Ravenna, RA, Italy
View Trial Details
Active, Not Recruiting

Study to Evaluate the Reinduction and Second Stop of TKI with Ponatinib in CML in Molecular Response (ResToP)

NCT04160546

Conditions
Bone Marrow Diseases, Chronic Disease, Chronic Myeloid Leukemia, Chronic Phase, +12 more
Locations
  • Institut Català D'Oncologia L'Hospitalet (ICO) L'Hospitalet de Llobregat, Barcelona, Spain
  • Hospital General Universitario Gregorio Marañón Madrid, Spain
  • Hospital Ramón y Cajal Madrid, Spain
  • Hospital Universitario y Politécnico La Fe Valencia, Spain
View all 13 locations
View Trial Details
Active, Not Recruiting

A Study to Evaluate the Efficacy and Safety of Ropeginterferon Alfa-2b in Essential Thrombocythaemia Patients

NCT06514807

Conditions
Blood Coagulation Disorders, Blood Platelet Disorders, Bone Marrow Diseases, +7 more
Locations
  • University Hospital Graz, Department of Internal Medicine, Clinical Department of Hematology Graz, Styria, Austria
  • Medical University Innsbruck, Department of Internal Medicine V (Hematology and Oncology) Innsbruck, Tyrol, Austria
  • Ordensklinikum Linz GmbH Elisabethinen Hospital, Department of Internal Medicine I - Hemato-Oncology Linz, Upper Austria, Austria
  • Medical University Vienna, Department of Internal Medicine I, Clinical Department of Hematology and Hemostaseology Vienna, Austria
View all 36 locations
View Trial Details

Related conditions